AT
Schedule 13G filing
AdvisorShares Trust disclosed a 5.8% stake in Neuphoria Therapeutics Inc. (NEUP)
AdvisorShares Trust reported owning 5.8% of Neuphoria Therapeutics Inc. (NEUP) (312,895 shares) in a Schedule 13G filed Oct 5, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 5, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.